Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
NCT01927055Phase 3Terminated
- Sponsor
- Chelsea Therapeutics International, Ltd.
- Start
- Nov 2013
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of droxidopa in Neurogenic Orthostatic Hypotension (nOH), sponsored by Chelsea Therapeutics International, Ltd.. Started Nov 2013; status: terminated.
02
Drugs
droxidopa
03
Conditions
Neurogenic Orthostatic Hypotension (nOH)
Beyond the preview
Go deeper on NCT01927055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01927055.